# Norgine clinical trials: 54 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 54 trials with Norgine as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Norgine: 54 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/norgine

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 54
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 54, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 20, 2025 | NCT07218523 | A Study to Investigate Bowel Cleansing With PLENVU® Compared to Sodium Picosulfate in Participants Aged 1 to \< 18 Years of Age in... | Norgine | Phase 3 | Recruiting | Bowel Cleansing Prior to Clinical Procedures | 212 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07218523) |
| September 19, 2024 | NCT06597903 | A Monocentric Study to Investigate a New Low Dose Oral Gut Cleansing Solution | Norgine | Phase 2 | Completed | Colorectal Cancer | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06597903) |
| September 19, 2024 | NCT06593743 | The Safety and Dose Response to Single Anal Doses of NRL001 | Norgine | Phase 1 | Completed | Faecal Incontinence | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06593743) |
| September 19, 2024 | NCT06593730 | Safety and Tolerability of the Twice Daily Intra-anal Application of NRL001 Cream for 14 Days | Norgine | Phase 1 | Completed | Faecal Incontinence | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06593730) |
| January 3, 2022 | NCT05174845 | Real Word Evidence With 1L Polyethylene Glycol (PEG)+ Ascorbic Acid in Iberia | Norgine | Observational | Completed | Colon Cancer, Colon Disease, Colon Cleansing | 13,393 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05174845) |
| February 19, 2018 | NCT03437265 | A Pharmacokinetic Study of PLENVU® in Healthy Subjects | Norgine | Phase 1 | Completed | Pharmacokinetic | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03437265) |
| July 2, 2015 | NCT02488993 | Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin (PROSPER) | Norgine | Observational | Completed | Hepatic Encephalopathy | 389 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02488993) |
| June 11, 2015 | NCT02468726 | Performance of NER1008 Enema Compared With Fleet® Enema in Bowel Cleansing | Norgine | Not applicable | Completed | Colorectal Cancer | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02468726) |
| October 23, 2014 | NCT02273167 | Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus... | Norgine | Phase 3 | Completed | Colorectal Cancer, Colorectal Carcinoma, Colon Cleansing | 849 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02273167) |
| October 23, 2014 | NCT02273141 | Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus a... | Norgine | Phase 3 | Completed | Colorectal Cancer, Colorectal Carcinoma, Colon Cleansing | 515 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02273141) |
| October 2, 2014 | NCT02254486 | Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus... | Norgine | Phase 3 | Completed | Colon Cancer, Colorectal Carcinoma, Colon Cleansing | 621 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02254486) |
| April 18, 2013 | NCT01834742 | Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using... | Norgine | Phase 1 | Completed | Colorectal Cancer | 161 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01834742) |
| October 26, 2012 | NCT01715272 | A Clinical Investigation to Demonstrate the Performance of a New Enema (TF037) in Distal Bowel Cleansing Compared With Fleet Enema | Norgine | Phase 1 | Completed | Colonoscopy | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01715272) |
| October 26, 2012 | NCT01714466 | Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing... | Norgine | Phase 2 | Completed | Colon Cancer | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01714466) |
| October 19, 2012 | NCT01710995 | A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg... | Norgine | Phase 1 | Completed | Acid Reflux, Gastro Oesophageal Reflux Disease | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01710995) |
| October 19, 2012 | NCT01710982 | Study to Evaluate the Safety of Post-Operative TZP-101 (IV Ulimorelin) After Partial Bowel Resection | Norgine | Phase 3 | Completed | Postoperative Ileus | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01710982) |
| September 21, 2012 | NCT01689792 | A Multi-centre Study Comparing the Polyp Detection Rate of Two Different Types of Bowel Preparation: a 2-litre Solution (MOVIPREP®) Versus... | Norgine | Phase 4 | Completed | Colorectal Cancer | 398 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01689792) |
| August 17, 2012 | NCT01668199 | A Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery and Pharmacokinetics of 14C TZP-101 | Norgine | Phase 1 | Completed | Postoperative Ileus | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01668199) |
| August 3, 2012 | NCT01656720 | A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal... | Norgine | Phase 2 | Completed | Faecal Incontinence | 417 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01656720) |
| June 22, 2012 | NCT01626196 | Evaluation of the Main Determinants of Patient Acceptability of the Bowel Cleansing Procedure, and of Success of Bowel Cleansing and Caecal... | Norgine | Observational | Completed | Routine Colonoscopy | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01626196) |
| December 15, 2011 | NCT01493089 | Phase III Study Comparing Zegerid® With Losec® for the Relief of Heartburn Associated With Gastroesophageal Reflux Disease | Norgine | Phase 3 | Completed | Gastroesophageal Reflux | 239 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01493089) |
| August 1, 2011 | NCT01406925 | Safety and Tolerability of a Single Intra-anal Dose of NRL001 in Healthy Volunteers | Norgine | Phase 1 | Completed | Fecal Incontinence | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01406925) |
| July 29, 2011 | NCT01405612 | Study to Examine the Effect of Ulimorelin on the Pharmacokinetics of Midazolam in Healthy Volunteers | Norgine | Phase 1 | Completed | Digestive System Disorders | 14 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01405612) |
| July 29, 2011 | NCT01405599 | Evaluation of the Pharmacokinetics of Ulimorelin in Subjects With Hepatic Impairment and Healthy Subjects | Norgine | Phase 1 | Completed | Digestive System Disorders | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01405599) |
| December 2, 2010 | NCT01251822 | Comparator Study of PEG 3350 Versus Prucalopride in Females With Chronic Constipation | Norgine | Phase 3 | Completed | Constipation | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01251822) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 23 |
| Phase 1/2 | 1 |
| Phase 2 | 10 |
| Phase 3 | 14 |
| Phase 4 | 2 |
| Not applicable | 1 |
| Observational | 3 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 53 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Colorectal Neoplasms | 7 |
| Fecal Incontinence | 6 |
| Liver Cirrhosis | 5 |
| Colonic Neoplasms | 4 |
| Constipation | 3 |
| Encopresis | 3 |
| Non-alcoholic Fatty Liver Disease | 2 |
| Gastroesophageal Reflux | 2 |
| Digestive System Diseases | 2 |
| Hepatic Encephalopathy | 1 |
| Fecal Impaction | 1 |
| Fibrosis | 1 |
| Gastrointestinal Diseases | 1 |
| Irritable Bowel Syndrome | 1 |
| Hepatitis, Viral, Human | 1 |
| Colonic Diseases | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Vascular medicine practices in the United States](https://specstream.ai/data/businesses/vascular-medicine-practices/united-states)
- [Medical service organizations in the United States](https://specstream.ai/data/businesses/medical-service-organizations/united-states)
- [Credit unions in the United States](https://specstream.ai/data/businesses/credit-unions/united-states)
- [Traffic ticketing law firms in the United States](https://specstream.ai/data/businesses/traffic-ticketing-law-firms/united-states)
- [Logging contractors in the United States](https://specstream.ai/data/businesses/logging-contractors/united-states)
- [Commercial refrigeration companies in the United States](https://specstream.ai/data/businesses/commercial-refrigeration-companies/united-states)
